NATCO Pharma Limited (NSE: NATCOPHARM)
India
· Delayed Price · Currency is INR 1,559.90
+4.15 (0.27%)
Sep 6, 2024, 3:30 PM IST
NATCO Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 6, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 279,393 | 170,522 | 102,795 | 138,013 | 150,529 | 92,044 | Upgrade
|
| Market Cap Growth | 68.33% | 65.89% | -25.52% | -8.31% | 63.54% | -12.17% | Upgrade
|
| Enterprise Value | 264,613 | 160,841 | 93,605 | 133,992 | 144,005 | 84,751 | Upgrade
|
| Last Close Price | 1559.90 | 950.21 | 556.13 | 739.81 | 803.46 | 488.31 | Upgrade
|
| PE Ratio | 17.07 | 12.29 | 14.19 | 79.38 | 33.26 | 19.33 | Upgrade
|
| PS Ratio | 6.42 | 4.13 | 3.80 | 7.09 | 7.32 | 4.81 | Upgrade
|
| PB Ratio | 4.78 | 2.91 | 2.11 | 3.24 | 3.65 | 2.43 | Upgrade
|
| P/FCF Ratio | - | 19.55 | 14.63 | -74.08 | 340.56 | 149.42 | Upgrade
|
| P/OCF Ratio | - | 14.07 | 12.11 | 296.80 | 50.38 | 22.06 | Upgrade
|
| EV/Sales Ratio | 6.08 | 3.90 | 3.46 | 6.88 | 7.00 | 4.43 | Upgrade
|
| EV/EBITDA Ratio | 12.23 | 8.56 | 9.68 | 51.54 | 23.74 | 14.56 | Upgrade
|
| EV/EBIT Ratio | 13.44 | 9.50 | 11.56 | 108.58 | 29.19 | 17.45 | Upgrade
|
| EV/FCF Ratio | - | 18.44 | 13.32 | -71.92 | 325.80 | 137.58 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.04 | 0.10 | 0.07 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 0.17 | 0.20 | 0.18 | 1.64 | 0.47 | 0.57 | Upgrade
|
| Debt / FCF Ratio | - | 0.43 | 0.25 | -2.32 | 6.42 | 5.35 | Upgrade
|
| Asset Turnover | - | 0.66 | 0.50 | 0.39 | 0.44 | 0.43 | Upgrade
|
| Inventory Turnover | - | 0.95 | 0.78 | 0.66 | 0.66 | 0.63 | Upgrade
|
| Quick Ratio | - | 3.12 | 2.87 | 2.02 | 2.48 | 2.23 | Upgrade
|
| Current Ratio | - | 4.14 | 4.39 | 3.50 | 4.46 | 3.39 | Upgrade
|
| Return on Equity (ROE) | - | 25.88% | 15.66% | 4.05% | 11.19% | 12.59% | Upgrade
|
| Return on Assets (ROA) | - | 16.84% | 9.40% | 1.56% | 6.57% | 6.83% | Upgrade
|
| Return on Capital (ROIC) | 21.85% | 18.77% | 10.39% | 1.69% | 7.24% | 7.60% | Upgrade
|
| Earnings Yield | 5.86% | 8.14% | 6.96% | 1.23% | 2.93% | 5.01% | Upgrade
|
| FCF Yield | 5.11% | 6.84% | -1.35% | 0.29% | 0.67% | Upgrade
| |
| Dividend Yield | 0.35% | 1.00% | 0.99% | 0.61% | 0.65% | 1.38% | Upgrade
|
| Payout Ratio | 0.00% | 12.30% | 14.04% | 48.35% | 25.83% | 27.65% | Upgrade
|
| Buyback Yield / Dilution | 1.64% | 1.67% | -0.08% | 0.05% | -0.02% | 1.26% | Upgrade
|
| Total Shareholder Return | 1.99% | 2.67% | 0.91% | 0.65% | 0.63% | 2.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.